The most prescribed IV iron in the US

MORE THAN 25 MILLION PATIENTS TREATED GLOBALLY WITH OVER 500 MILLION UNITS.2*

Venofer® (iron sucrose) injection, USP is an established and effective treatment for chronic kidney disease (CKD) patients experiencing iron deficiency anemia (IDA).

About Venofer

Venofer provides IV iron therapy for the treatment of IDA in adult and pediatric patients 2 years and older with CKD. The dosing for iron replacement treatment in pediatric patients with peritoneal-dialysis-dependent CKD, hemodialysis-dependent CKD, or non-dialysis-dependent CKD has not been established.

*Patients are calculated based on an estimated annual cumulative dose. Data on file, American Regent, Inc.

DOSING & ADMINISTRATION

Find Venofer dosing and administration instructions for adult and pediatric patients with CKD.

Venofer Patient Support Program

We've developed a program to provide Venofer free of charge to eligible patients who lack insurance coverage.

Providers (hospitals, physicians or infusion centers) may apply to the program on behalf of their patients.

DETAILS & FORMS

American Regent, Inc. reserves the right to modify or cancel the program immediately with respect to any patient, or in its entirely, at any time.

Ordering & Reimbursement Support

Find Venofer ordering and reimbursement information, including coding assistance.

ORDERING & REIMBURSEMENT

Reimbursement Assistance

A service designed to help physicians and other providers understand payers’ coverage and reimbursement policies for Venofer.

877-4-IV-IRON (877-448-4766)

Monday through Friday, from 9 AM to 8 PM ET

REFERENCES

1. IQVIA [NSP Audit from MAT November 2013 to November 2018]. 2. Data on file. Iron Sucrose Periodic Safety Update Report, 2018. Shirley, NY: American Regent, Inc.